Investor Presentaiton

Well integrated company and expanding Globally Revenue break up (%) by segment (FY 10-11) Indian finished dosage formulations International finished dosage formulations High end APIs + intermediates Consumer Wellness APIs, 9% ▲8% India Formulations 38% " ▲ 19% Exports Formulations 43% ▲37% \India Others, 3% 16% India Consumer, 7% ▲ 25% Revenue break up (%) by region (FY 10-11) Regulated Mkts (US, EU, Japan), 40% ▲ 34% Manufacturing Research and Development India, 49% ▲ 19% Emerging Mkts, 11% ▲ 24% 4

View entire presentation